[News] EASL Congress 2026 | ClinicLens

24 weeks of treatment with the antisense oligonucleotide bepirovirsen, which targets all hepatitis B virus (HBV) transcripts, resulted in significantly more patients with chronic HBV infection achieving functional cure (defined as an HBV DNA level below the lower limit of quantif

Medical Literature · Updated 2026-08-03

← Back to articles

This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.